MAPT and early-onset autosomal dominant Alzheimer disease: It was reported that HSPA2 was not only significantly highly expressed in late-onset Alzheimer's disease (LOAD), but also further elevated Aβ40 and Aβ42 levels and phosphorylated-tau in two cell lines with HSPA2 overexpression [24].